| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 54 |
| 1 | PREDNISONE | 52 |
| 2 | METHOTREXATE | 42 |
| 3 | CYTARABINE | 38 |
| 4 | CYCLOPHOSPHAMIDE | 29 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 29 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 29 |
| 7 | METHYLPREDNISOLONE | 29 |
| 8 | PREDNISOLONE | 29 |
| 9 | PREDNISOLONE ORAL | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXRAZOXANE FOR INJECTION | 12 | 0.0127 |
| 1 | CLOFARABINE | 6 | 0.0026 |
| 2 | IDARUBICIN HYDROCHLORIDE | 2 | 0.0017 |
| 3 | PEGASPARGASE | 18 | 0.0015 |
| 4 | SODIUM POLYSTYRENE SULFONATE | 2 | 0.0013 |
| 5 | TAFASITAMAB-CXIX | 1 | 0.0011 |
| 6 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 7 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 8 | OXACILLIN SODIUM | 1 | 0.0009 |
| 9 | DEFLAZACORT | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 117 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 49 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 42 |
| 3 | Alkylating Drug [EPC] | 32 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 5 | Asparagine-specific Enzyme [EPC] | 18 |
| 6 | Microtubule Inhibitor [EPC] | 18 |
| 7 | Platinum-based Drug [EPC] | 17 |
| 8 | Topoisomerase Inhibitor [EPC] | 16 |
| 9 | Opioid Agonist [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 18 | 0.0013 |
| 1 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 2 | Androgen [EPC] | 10 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 8 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 49 | 0.0002 |